Paper38510656
Mechanism of traditional Chinese medicine in elderly diabetes mellitus and a systematic review of its clinical application.
Zhang Q and 5 others. Front Pharmacol, 2024. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Mechanism of traditional Chinese medicine in elderly diabetes mellitus and a systematic review of its clinical application. Papers, record 38510656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38510656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanism of traditional Chinese medicine in elderly diabetes mellitus and a systematic review of its clinical application.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References129
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37358764 | The role of GLUT2 in glucose metabolism in multiple organs and tissues. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/37358764 | PubMed |
| 2 | 28440590 | Sodium-glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis. | Diabetes Metab Res Rev | 2017 | https://conductscience.org/library/papers/28440590 | PubMed |
| 3 | 38242213 | Ferroptosis: Mechanisms and role in diabetes mellitus and its complications. | Ageing Res Rev | 2024 | https://conductscience.org/library/papers/38242213 | PubMed |
| 4 | 24432995 | Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial. | J Clin Endocrinol Metab | 2014 | https://conductscience.org/library/papers/24432995 | PubMed |
| 5 | 37904236 | Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37904236 | PubMed |
| 6 | 28397367 | Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus. | J Diabetes Investig | 2018 | https://conductscience.org/library/papers/28397367 | PubMed |
| 7 | 23737206 | Physiology of endothelin and the kidney. | Compr Physiol | 2011 | https://conductscience.org/library/papers/23737206 | PubMed |
| 8 | 17410143 | China plans to modernize traditional medicine. | Nature | 2007 | https://conductscience.org/library/papers/17410143 | PubMed |
| 9 | 23341580 | High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. | Cardiovasc Res | 2013 | https://conductscience.org/library/papers/23341580 | PubMed |
| 10 | 32963699 | Ginseng-Sanqi-Chuanxiong (GSC) Extracts Ameliorate Diabetes-Induced Endothelial Cell Senescence through Regulating Mitophagy via the AMPK Pathway. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/32963699 | PubMed |
| 11 | 21366473 | Long-term effects of intensive glucose lowering on cardiovascular outcomes. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21366473 | PubMed |
| 12 | 34329715 | The role of traditional Chinese medicine in the treatment of cognitive dysfunction in type 2 diabetes. | J Ethnopharmacol | 2021 | https://conductscience.org/library/papers/34329715 | PubMed |
| 13 | 37257702 | Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis. | J Ethnopharmacol | 2023 | https://conductscience.org/library/papers/37257702 | PubMed |
| 14 | 29425894 | Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage. | Vascul Pharmacol | 2018 | https://conductscience.org/library/papers/29425894 | PubMed |
| 15 | 15313123 | AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. | Microvasc Res | 2004 | https://conductscience.org/library/papers/15313123 | PubMed |
| 16 | 29180222 | Intranasal insulin in Alzheimer's disease: Food for thought. | Neuropharmacology | 2018 | https://conductscience.org/library/papers/29180222 | PubMed |
| 17 | 17724765 | Inhibition of non-enzymatic glycation by silk extracts from a Mexican land race and modern inbred lines of maize (Zea mays). | Phytother Res | 2008 | https://conductscience.org/library/papers/17724765 | PubMed |
| 18 | 26580237 | Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. | J Clin Endocrinol Metab | 2016 | https://conductscience.org/library/papers/26580237 | PubMed |
| 19 | 30834778 | Protective Effects of Ligustroflavone, an Active Compound from Ligustrum lucidum, on Diabetes-Induced Osteoporosis in Mice: A Potential Candidate as Calcium-Sensing Receptor Antagonist. | Am J Chin Med | 2019 | https://conductscience.org/library/papers/30834778 | PubMed |
| 20 | 36825725 | Total Flavonoids from Rhizoma Drynariae (Gusuibu) Alleviates Diabetic Osteoporosis by Activating BMP2/Smad Signaling Pathway. | Comb Chem High Throughput Screen | 2023 | https://conductscience.org/library/papers/36825725 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42871587 | Yishen Xiaoke Formula Delays Renal Fibrosis in Rats with Diabetic Nephropathy by Suppressing the Transforming Growth Factor-Beta 1/Notch Signalling Pathway. | Iran J Pharm Res | 2026 | https://conductscience.org/library/papers/42871587 | PubMed |
| 42381486 | Traditional Chinese Medicine for Diabetic Sarcopenia: A Review and Its Related Mechanisms. | J Diabetes Res | 2026 | https://conductscience.org/library/papers/42381486 | PubMed |
| 42057976 | Cellular and Molecular Mechanisms of Hyperglycemia-Induced Atherosclerosis and Intervention Strategies of Chinese Herbal Medicine. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42057976 | PubMed |
| 41852470 | Traditional Chinese medicine in diabetes management: a comprehensive review of mechanisms and therapeutic potential. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41852470 | PubMed |
| 41560725 | Randomized trial and multi-omics, machine learning-based mechanistic exploration of daixie decoction granules in type 2 diabetes. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41560725 | PubMed |
| 41127514 | Evaluating efficacy and mechanism of traditional Chinese medicine in diabetes treatment: a meta-analysis and network pharmacology study. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41127514 | PubMed |
| 41079734 | Uncovering the gut - skin axis: the role of specific traditional Chinese medicine interventions in regulating gut microbiota for diabetic foot ulcers and the analysis of research status. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41079734 | PubMed |
| 40417738 | Mechanism Analysis of Zuogui and Yougui Pills on Diabetic Nephropathy Through Transcriptional Regulatory Networks of HIF1A and PPARA. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/40417738 | PubMed |
| 40391051 | The Therapeutic Effect and Mechanism of Traditional Chinese Medicine in Type 2 Diabetes Mellitus and Its Complications. | Diabetes Metab Syndr Obes | 2025 | https://conductscience.org/library/papers/40391051 | PubMed |
| 39065801 | Dilemmas in Elderly Diabetes and Clinical Practice Involving Traditional Chinese Medicine. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39065801 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38510656
GET https://conductscience.org/api/papers/v1/38510656/references?page=2